COMPARATIVE IN VITRO AND IN VIVO EVALUATIONS OF NIOSOMAL GEL VS. CONVENTIONAL GEL PREPARATIONS FOR THE TREATMENT OF PSORIASIS

Megha Shyam Matlapudi; Anka Rao Areti; Yukti Jaiswal; Veeresh Bantal

doi:10.56782/pps.582

Published : 2025-10-12

No. 2025 (Early Access)

COMPARATIVE IN VITRO AND IN VIVO EVALUATIONS OF NIOSOMAL GEL VS. CONVENTIONAL GEL PREPARATIONS FOR THE TREATMENT OF PSORIASIS

Megha Shyam Matlapudi

Anka Rao Areti

Yukti Jaiswal

Veeresh Bantal

DOI: https://doi.org/10.56782/pps.582

Abstract

Psoriasis is a chronic inflammatory skin disease marked by excessive keratinocyte proliferation and immune dysregulation. While corticosteroids like Desonide are commonly used to alleviate symptoms, their limited skin permeability and potential systemic side effects restrict long-term use. This study aimed to develop and compare a novel niosomal gel formulation of Desonide (DG6) with a conventional Desonide gel (DG8), assessing their physicochemical properties, skin permeation, drug release behavior, and therapeutic efficacy in an imiquimod-induced mouse model of psoriasis. DES-loaded niosomes were prepared via the thin-film hydration technique and characterized for particle size, polydispersity index (PDI), zeta potential, entrapment efficiency, and morphology. Niosomes were incorporated into a carbomer-based gel to create DG6. Comparative evaluations of DG6 and DG8 were conducted using rheology studies, in vitro release, ex vivo skin permeation, and in vivo efficacy assessments, including PASI scoring, stratum corneum hydration, transepidermal water loss (TEWL), spleen index, and histopathological analyses. DG6 exhibited controlled and sustained drug release, higher skin deposition (192.3 ± 55.1 µg vs. 140.9 ± 51.7 µg for DG8), and significantly lower PASI scores in vivo (3.8 ± 1.0 vs. 6.4 ± 1.1). Histological evaluations showed notable restoration of normal skin architecture with DG6 treatment, with reduced epidermal hyperplasia, parakeratosis, and inflammatory cell infiltration. Rheological studies confirmed favorable spreadability and mechanical strength comparable to a marketed formulation. The niosomal gel formulation demonstrated superior skin localization, therapeutic efficacy, and barrier restoration over the conventional gel. These findings underscore the potential of niosomal systems in enhancing topical corticosteroid therapy for psoriasis.

Keywords:

Desonide Niosomal Gel, Psoriasis, Skin Permeation, In vivo assessment

Similar Articles

Anna Szymanowska, Agnieszka Gornowicz, Anna Bielawska, Krzysztof Bielawski, PLANT STEM CELLS AND THEIR APPLICATION IN COSMETOLOGY AND REGENERATIVE MEDICINE , Prospects in Pharmaceutical Sciences: Vol. 17 No. 7 (2019)

<< < 1 2 3 4 5

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Matlapudi, M. S., Areti, A. R., Jaiswal, Y., & Bantal, V. (2025). COMPARATIVE IN VITRO AND IN VIVO EVALUATIONS OF NIOSOMAL GEL VS. CONVENTIONAL GEL PREPARATIONS FOR THE TREATMENT OF PSORIASIS. Prospects in Pharmaceutical Sciences, (2025 (Early Access). https://doi.org/10.56782/pps.582

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

[1] Wang, K.; Zhao, Y.; Cao, X. Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030. Arch. Dermatol. Res. 2024,316(4),114. https://doi.org/10.1007/s00403-024-02846-z

[2] Rapalli, V.K.; Singhvi, G.; Dubey, S.K.; Gupta, G.; Chellappan, D.K.; Dua, K. Emerging landscape in psoriasis management: From topical application to targeting biomolecules. Biomed. Pharmacother. 2018,106,707-713. https://doi.org/10.1016/j.biopha.2018.06.136

[3] Lowes, M.A.; Suárez-Fariñas, M.; Krueger, J.G. Immunology of psoriasis. Annu. Rev. Immunol. 2014,32,227-255. https://doi.org/10.1146/annurev-immunol-032713-120225

[4] Patient information leaflet of Desonide cream & Lotion (Desowen) available at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7e5f030-b849-4805-94e6-f45631eaa37f

[5] Ma, Q.; Zhang, J.; Lu, B.; Linm H.; Sarkar, R.; Wu, T.; Li, X. Nanoemulgel for Improved Topical Delivery of Desonide: Formulation Design and Characterization. AAPS PharmSciTech. 2021,22,163. https://doi.org/10.1208/s12249-021-02035-5

[6] Uva, L.; Miguel, D.; Pinheiro, C.; Antunes, J.; Cruz, D.; Ferreira, J.; Filipe, P. Mechanisms of action of topical corticosteroids in psoriasis. Int. J. Endocrinol. 2012,2012(1), 561018. https://doi.org/10.1155/2012/561018

[7] Sharma, K; Sapra, B; Kant, S; Bedi, N. Formulation and Evaluation of Desonide Loaded Microemulsion Based Gel for Management of Atopic Dermatitis. J. Nanomed. 2021,4(1),1035.

[8] Zhang, J.; Yao, Y.; Liu, H.; Ma, Q.; Huang, L.; Chen, Y.; Lin, H. Desonide Nanoemulsion Gel for Transdermal Absorption Drug Delivery: Pharmacodynamic and Safety Evaluation. Curr. Drug Deliv. 2023,20(10),1525-1532. https://doi.org/10.2174/1567201819666220819110128

[9] Seenivasan, K.; Priyadharshini, R.; Barish; Mahalakshmi, S. Formulation and evaluation of desonide ethosomal gel. Int. J. Res. Pharm and Pharm Sci. 2024,9(3),49-53.

[10] Antonow, M.B.; Lorenzoni, R.; Barbosa, G.M.; Ourique, A.F.; Gomes, P.; Raffin, R.P. Development and Physicochemical Characterization of Desonide-Loaded Nanocapsule Suspensions. Adv. Mater. Sci. Eng. 2016,2016,7395896. http://dx.doi.org/10.1155/2016/7395896

[11] Rosa, P.; Friedrich, M.L.; dos Santos, J.; Pegoraro, N.S.; Camponogara, C.; Oliveira, S.M.; Adams, A.I.H.; de Bona da Silva, C. Development of a nanotechnological hydrogel containing desonide nanocapsules in association with acai oil: design and in vivo evaluation. Pharm. Dev. Technol. 2022,27(6),654–664. https://doi.org/10.1080/10837450.2022.2103147

[12] Todke, P.; Shah, V.H. Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches. Int. J. Dermatol. 2018,57(11),1387–1402. https://doi.org/10.1111/ijd.14047

[13] Cerqueira-Coutinho, C.; Dos Santos, E.P.; Mansur, C.R. Niosomes as Nano-Delivery Systems in the Pharmaceutical Field. Crit. Rev. Ther. Drug Carrier Syst. 2016,33(2),195–212. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2016016167

[14] Zaid Alkilani, A.; Hamed, R.; Abdo, H.; Swellmeen, L.; Basheer, H.A.; Wahdan, W.; Abu Kwiak A.D. Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study. ACS Omega. 2022,7(44),39782-39793.https://doi.org/10.1021/acsomega.2c03762

[15] Patel, K.K.; Kumar, P.; Thakkar, H.P. Formulation of Niosomal Gel for Enhanced Transdermal Lopinavir Delivery and Its Comparative Evaluation with Ethosomal Gel. AAPS PharmSciTech. 2012,13,1502–1510. https://doi.org/10.1208/s12249-012-9871-7

[16] Matlapudi, M.S.; Areti, A.R. Formulation and Evaluation of Desonide Loaded Niosomes Prepared by Film Hydration Technique Using Box-Behnken Design. in Current Trends in Drug Discovery, Development and Delivery (CTD4-2022), ed. M. Murahari, B. N. Nalluri, and G. Chakravarthi, Royal Society of Chemistry. 2023,358,351-360. https://doi.org/10.1039/9781837671090-00351

[17] Pandey, S.S.; Shah, K.M.; Maulvi, F.A.; Desai, D.T.; Gupta, A.; Joshi, S.V.; Shah, D.O. Topical delivery of cyclosporine loaded tailored niosomal nanocarriers for improved skin penetration and deposition in psoriasis: Optimization, ex vivo and animal studies. J. Drug Deliv. Sci. Technol. 2021,63,102441.https://doi.org/10.1016/j.jddst.2021.102441

[18] Soni, S.; Baghel. K.; Soni. M.L.; Kashaw. S.K.; Soni, V. Size-dependent effects of niosomes on the penetration of methotrexate in skin layers. Futur. J. Pharm. Sci. 2024,10(48),1-18. http://doi.org/10.1186/s43094-024-00624-2

[19] Qiu, F.; Xi, L.; Chen, S.;l Zhao, Y.; Wang, Z.; Zheng, Y. Celastrol Niosome Hydrogel Has Anti-Inflammatory Effect on Skin Keratinocytes and Circulation without Systemic Drug Exposure in Psoriasis Mice. Int. J. Nanomedicine. 2021,16,6171-6182. https://doi.org/10.2147/IJN.S323208

[20] El-Say, K.M.; Abd-Allah, F.I.; Lila, A.E.; Hassan Ael-,S.; Kassem, A.E. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. J. Liposome Res. 2016,26(1),57-68. https://doi.org/10.3109/08982104.2015.1029495

[21] Matlapudi, M.S.; Areti, A.R.; Jaiswal, Y.; Bantal, V.; Medishetti, R. Enhancing topical drug delivery of Apremilast through niosomal gel formulation: Ex vivo skin permeation and in vivo evaluation for psoriasis. Thai J. Pharm. Sci. 2025,49(1),3. https://doi.org/10.56808/3027-7922.2978

[22] Sathe, P.; Saka, R.; Kommineni, N.; Raza, K.; Khan, W. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug Dev. Ind. Pharm. 2019,45(5),826–838. https://doi.org/10.1080/03639045.2019.1576722

[23] Obeid, M.A.; Khadra, I.; Aljabali, A.A.A.; Amawi, H.; Ferro, V.A. Characterisation of niosome nanoparticles prepared by microfluidic mixing for drug delivery. Int. J. Pharm. X. 2022,4,100137. https://doi.org/10.1016/j.ijpx.2022.100137

[24] Gouda, R.; Baishya, H.; Qing, Z. Application of Mathematical Models in Drug Release Kinetics of Carbidopa and Levodopa ER Tablets. J. Develop. Drugs. 2017,6(2),1-8. https://doi.org/10.4172/2329-6631.1000171

[25] Mahdavi Moghddam, S.R.; Ahad, A; Aqil, M; Imam, S.S.; Sultana, Y. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. Mater. Sci. Eng. C. 2016,69,789–797. https://doi.org/10.1016/j.msec.2016.07.043

[26] Bhardwaj, P.; Tripathi, P.; Pandey, S.; Gupta, R.; Patil, P.R. Cyclosporine and Pentoxifylline laden tailored niosomes for the effective management of psoriasis: In-vitro optimization, Ex-vivo and animal study. Int. J. Pharm. 2022,626,122143. https://doi.org/10.1016/j.ijpharm.2022.122143

[27] Fadaei, M.S.; Fadaei, M.R.; Kheirieh, A.E.; Rahmanian-Devin, P.; Dabbaghi, M.M.; Nazari Tavallaei, K.; Shafaghi, A.; Hatami, H.; Baradaran Rahimi, V.; Nokhodchi, A.; Askari, V.R. Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds. EXCLI J. 2024,23,212-263. https://doi.org/10.17179/excli2023-6868

[28] Neu, S.D.; Strzepa, A.; Martin, D.; Sorci-Thomas, M.G.; Pritchard, K.A.Jr; Dittel, B.N. Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice. Antioxidants. 2021,10(9),1338. https://doi.org/10.3390/antiox10091338

[29] Guo, J.W.; Cheng, Y.P.; Liu, C.Y.; Thong, H.Y.; Huang, C.J.; Lo, Y.; Wu, C.Y.; Jee, S.H. Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-Induced Psoriasis-Like Dermatitis in Mice. Pharmaceutics. 2020, 12(5), 457. https://doi.org/10.3390/pharmaceutics12050457

[30] Xu, Y.; Shi, Y.; Huang, J.; Gu, H.; Li, C.; Zhang, L.; Liu, G.; Zhou, W.; Du, Z. The Essential Oil Derived from Perilla frutescens (L.) Britt. Attenuates Imiquimod-Induced Psoriasis-like Skin Lesions in BALB/c Mice. Molecules. 2022,27(9),2996. https://doi.org/10.3390/molecules27092996

Megha Shyam Matlapudi

meghashyam.3@gmail.com
https://orcid.org/0009-0009-4309-9454

Affiliation:

Koneru Lakshmaiah Educational Foundation India

Bio Statement (e.g., department and rank)

Research Scholar at KL University, Koneru Lakshmaiah Eucational Foundation.

Anka Rao Areti

ankarao@kluniversity.in

Affiliation:

Koneru Lakshmaiah Educational Foundation India

Bio Statement (e.g., department and rank)

Associate Professor and Vice Principal of KL College of Pharmacy, KL UNiversity (Koneru Lakshmaiah Educational Foundation)

Yukti Jaiswal

yukti.jaiswal2@gmail.com
https://orcid.org/0009-0003-6555-8523

Affiliation:

G. Pulla Reddy College of Pharmacy India

Bio Statement (e.g., department and rank)

Research scholar in the Department of Pharmacology at G. Pulla Reddy College of Pharmacy

Veeresh Bantal

veereshsetty@gmail.com

Affiliation:

G. Pulla Reddy College of Pharmacy India

Bio Statement (e.g., department and rank)

Head of the Department - Department of Pharmacology at G. Pulla Reddy College of Pharmacy